Available funding totaling EUR 20 million dedicated to developing novel solid tumor treatments addressing a high unmet medical needSpringboard Health Angels, Pluton Asset Holding AG, Sintra Limited, ...
The well-preserved remains of a woolly mammoth found in Siberia enabled scientists to extract RNA for the first time and ...
AtomVie Global Radiopharma (AtomVie), a leading radiopharmaceutical CDMO, announced that it has successfully supplied the ...
The global perovskite solar cell market size is expected to be worth over USD 3,604.85 million by 2034, increasing from USD ...
New investors Tencent and BGF joined by all existing major shareholders Funds will advance pipeline of novel TCR-CD3 bispecifics in cancer and autoimmune disease 13 November 2025; Cambridge, England – ...
RION LAUNCHES RION VET TO TRANSFORM ANIMAL HEALTH WITH FIRST-IN-CLASS BIOLOGIC THERAPEUTIC; APPOINTS INDUSTRY LEADER MARK HERTHEL AS CEO; ANNOUNCES SERIES A FULFILLMENT RION, a clinical-stage ...
AdvanCell Pty Ltd ("AdvanCell"), a clinical-stage radiopharmaceutical company developing innovative targeted alpha therapies for cancer, today announced the appointment of Philina Lee, PhD as Chief ...
The autoimmune disorder destroys the body's ability to produce insulin. Some patients in experimental trials have gotten it back.
Founded in 1896, DelVal has been cited by the National Society for Experiential Education as having the country’s top experiential learning program, by Princeton Review as one of the best colleges in ...
Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) ("Innate" or the "Company") today announces its participation in the Jefferies Global Healthcare Conference 2025. Members of its executive team ...
Detailed price information for Stoke Therapeutics Inc (STOK-Q) from The Globe and Mail including charting and trades.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback